Range
9.08 - 9.15
Vol / Avg.
349.2K/1.4M
Div / Yield
-
52 Wk
3.2 - 9.28
Mkt Cap
413M
Payout Ratio
-
Open
9.08
P/E
-
EPS
-0.24
Shares
45.3M
Outstanding
45.3M
Total Float
36.5M
Sector: Health Care.Industry: Biotechnology
Kindred Biosciences Inc is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. The company identifies targets that have already demonstrated safety and efficacy in humans and develop therapeutics based on these validated targets for dogs and cats. It has a pipeline of novel biologics in development across many therapeutic classes, alongside biologics manufacturing capabilities and a broad intellectual property portfolio.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.240-0.240 0.0000
REV3.450M2.395M-1.055M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
KINKindred Biosciences0%413M

Kindred Biosciences Frequently Asked Questions

Q

How do I buy Kindred Biosciences (KIN) stock?

A

You can purchase shares of Kindred Biosciences (NASDAQ: KIN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kindred Biosciences's (KIN) competitors?

Q

What is the target price for Kindred Biosciences (KIN) stock?

A

The latest price target for Kindred Biosciences (NASDAQ: KIN) was reported by Lake Street on June 17, 2021. The analyst firm set a price target for 9.25 expecting KIN to rise to within 12 months (a possible 1.54% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kindred Biosciences (KIN)?

A

The stock price for Kindred Biosciences (NASDAQ: KIN) is $9.11 last updated Today at 8:00:02 PM.

Q

Does Kindred Biosciences (KIN) pay a dividend?

A

There are no upcoming dividends for Kindred Biosciences.

Q

When is Kindred Biosciences (NASDAQ:KIN) reporting earnings?

A
Kindred Biosciences’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Kindred Biosciences (KIN) going to split?

A

There is no upcoming split for Kindred Biosciences.

Q

What sector and industry does Kindred Biosciences (KIN) operate in?

A

Kindred Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.